Nath Tuheen S, Mohamed Nida, Gill Paramjot K, Khan Safeera
Surgical Oncology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Surgical Oncology, Tata Medical Centre, Kolkata, IND.
Cureus. 2022 May 29;14(5):e25443. doi: 10.7759/cureus.25443. eCollection 2022 May.
Video-assisted thoracoscopic surgery (VATS) is considered the standard procedure for surgical resection in non-small-cell lung cancer (NSCLC). However, there is still lingering speculation on its adequacy of lymph node (LN) dissection or sampling and the long-term survival benefits when compared to open thoracotomy. Given the above, we conducted a systematic review comparing VATS and thoracotomy in terms of their oncological effectiveness in resection. We explored major research literature databases and search engines such as MEDLINE, PubMed, PubMed Central, Google Scholar, and ResearchGate to find pertinent articles. After the meticulous screening, quality check, and applying relevant filters according to our eligibility criteria, we identified 16 studies relevant to our research question, out of which one was a randomized controlled trial, one meta-analysis, and 14 were observational studies. The study comprised 44,673 patients with NSCLC, out of whom 15,093 patients were operated by VATS and the remaining 29,580 patients by thoracotomy. The results indicate that VATS is equivalent to thoracotomy in total LNs (N1 + N2) and LN stations dissected. However, a thoracotomy may achieve slightly better mediastinal lymph node dissection (N2) in terms of assessing a greater number of mediastinal lymph nodes and nodal stations. This may be attributed to a better visual field during mediastinal nodal clearance by an open approach. Also, nodal upstaging was consistently more common with an open approach. In terms of long-term outcomes, both overall survival and disease-free survival rates were similar between the two groups, with VATS offering a slightly better survival benefit. Irrespective of the increased rates of nodal upstaging by an open approach, we conclude that VATS should be considered a highly efficient alternative to thoracotomy in both early and locally advanced NSCLC.
电视辅助胸腔镜手术(VATS)被认为是非小细胞肺癌(NSCLC)手术切除的标准术式。然而,与开胸手术相比,其在淋巴结(LN)清扫或采样的充分性以及长期生存获益方面仍存在诸多猜测。鉴于此,我们进行了一项系统评价,比较VATS和开胸手术在切除肿瘤方面的有效性。我们检索了主要的研究文献数据库和搜索引擎,如MEDLINE、PubMed、PubMed Central、谷歌学术和ResearchGate,以查找相关文章。经过细致的筛选、质量检查,并根据我们的纳入标准应用相关筛选条件后,我们确定了16项与我们研究问题相关的研究,其中1项是随机对照试验,1项是荟萃分析,14项是观察性研究。该研究纳入了44,673例NSCLC患者,其中15,093例患者接受了VATS手术,其余29,580例患者接受了开胸手术。结果表明,VATS在总的淋巴结(N1 + N2)和清扫的淋巴结站方面与开胸手术相当。然而,就评估更多的纵隔淋巴结和淋巴结站而言,开胸手术在纵隔淋巴结清扫(N2)方面可能略胜一筹。这可能归因于开放手术在纵隔淋巴结清除过程中具有更好的视野。此外,开放手术中淋巴结分期上调的情况始终更为常见。在长期预后方面,两组的总生存率和无病生存率相似,VATS的生存获益略好。尽管开放手术导致淋巴结分期上调的比例增加,但我们得出结论,在早期和局部晚期NSCLC中,VATS都应被视为开胸手术的高效替代方案。